ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2132

Angiogenesis and VEGF-Expressing Cells Are Identified Predominantly in the Fascia Rather Than the Muscle in the Early Phase of Dermatomyositis

Ken Yoshida1,2, Haruyasu Ito1, Kazuhiro Furuya1, Taro Ukichi1, Kentaro Noda1 and Daitaro Kurosaka1, 1Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan, 2Internal Medicine, Jikei University School of Medicine, Tokyo, Japan

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Angiogenesis, cytokines, dermatomyositis, inflammation and polymyositis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Muscle Biology, Myositis and Myopathies Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: We previously showed that fasciitis is a frequent manifestation of the disease in dermatomyositis (DM) but not in polymyositis (PM) and that DM-associated fasciitis is detected, as the result of the increased vascularity in the fascia, by power Doppler ultrasonography. We examined whether angiogenesis and vascular endothelial growth factor (VEGF)-expressing cells in the fascia are histologically identified in the early phase of DM, and whether inflammation is involved in angiogenesis and an increased number of VEGF-expressing cells.

Methods: We prospectively evaluated en bloc biopsy specimens obtained from 22 patients with DM and 11 patients with PM before treatment. Immunohistochemical staining for CD31, VEGF, and TNF-α were performed. The total vascular inflammation score (TVIS) was defined as the total number of aggregates of ≥50 perivascular inflammatory cells per 4-mm2area in the 3 fields with the most remarkable infiltration of perivascular inflammatory cells to quantify the degree of inflammation. The angiogenesis score (AS) was defined as the total number of CD31-positive blood vessels in 3 high-power fields (200×) that showed the most remarkable proliferation of the vessels. The numbers of VEGF- and TNF-α-expressing cells were counted in the 3 high-power fields (400×) that showed the largest accumulation of these cells. The TVIS, AS, and numbers of VEGF- and TNF-α-expressing cells were statistically analyzed in the fascia and muscle tissues.

Results: The AS, the number of VEGF-expressing cells, and the TVIS in the fascia of patients with DM were significantly higher compared with those of patients with PM; no significant difference was found in the muscle of patients with DM and PM. The number of VEGF-expressing cells in the fascia was correlated with the AS of patients with DM. In the early phase (the period from the onset of muscle symptoms until the biopsy <2monthes) of DM, the AS, the number of VEGF-expressing cells, and the TVIS in the fascia were significantly greater compared with the muscle. However, no significant differences were observed between the muscle and fascia in the late phase (the period ≥2) of DM. In patients with DM, the TVIS was correlated with the AS in the fascia, while the number of TNF-α-expressing cells was correlated with the TVIS and the number of VEGF-expressing cells in the fascia.

Conclusion: Angiogenesis, the number of VEGF-expressing cells, and the TVIS were higher in the fascia of patients with DM in comparison to patients with PM, and were increased predominantly in the fascia rather than the muscle in early-phase DM. Our data suggest that the angiogenesis induced by VEGF may progress from the fascia into the muscle in patients with DM. The degree of inflammation was correlated with that of angiogenesis in the fascia of patients with DM. These data suggest that the fascia can be a primary site of inflammation and angiogenesis in the pathogenesis of DM.


Disclosure: K. Yoshida, None; H. Ito, None; K. Furuya, None; T. Ukichi, None; K. Noda, None; D. Kurosaka, None.

To cite this abstract in AMA style:

Yoshida K, Ito H, Furuya K, Ukichi T, Noda K, Kurosaka D. Angiogenesis and VEGF-Expressing Cells Are Identified Predominantly in the Fascia Rather Than the Muscle in the Early Phase of Dermatomyositis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/angiogenesis-and-vegf-expressing-cells-are-identified-predominantly-in-the-fascia-rather-than-the-muscle-in-the-early-phase-of-dermatomyositis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/angiogenesis-and-vegf-expressing-cells-are-identified-predominantly-in-the-fascia-rather-than-the-muscle-in-the-early-phase-of-dermatomyositis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology